SmartBio Analytics provides GLP-compliant bioanalytical method validation services for pharmaceutical, biotechnology and research organisations. Our team validates analytical methods according to international regulatory guidelines, ensuring accurate, reliable and regulatory-ready data for preclinical and clinical studies.
It is a critical step: the accuracy, sensitivity, and reliability of the analytical method directly determine the quality and regulatory acceptance of your data.
Choosing the optimal LC/MS setup (HPLC-MS, UPLC-MS) based on the analyte’s nature, sample matrix, and study goals.
Fine-tuning chromatographic conditions, mass spectrometry settings, and sample preparation to maximize sensitivity and selectivity.
Establishing accurate calibration curves with well-characterized standards.
Identifying and minimizing ion suppression or enhancement to ensure precise quantification.
On average, we develop custom methods in 1–2 weeks, allowing your project to progress without delays
Our team combines extensive LC/MS bioanalysis experience with deep knowledge in pharmacokinetics, bioequivalence, and biomarker quantification
From innovative and generic small molecules to peptides, oligonucleotides, lipids, and proteins, we tailor each method to your specific analyte
Advanced LC/MS platforms delivering high sensitivity and reproducibility
Robust quality control under GLP standards to ensure data integrity
We work closely with your team to design methods aligned with your research and regulatory needs
Clear updates and transparent timelines from day one
With SmartBio Analytics, you don’t just get a method,
you get a validated, reliable tool designed to generate data you can trust, faster.
